These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18801902)
1. Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor. Tan K; Pogozheva ID; Yeo GS; Hadaschik D; Keogh JM; Haskell-Leuvano C; O'Rahilly S; Mosberg HI; Farooqi IS Endocrinology; 2009 Jan; 150(1):114-25. PubMed ID: 18801902 [TBL] [Abstract][Full Text] [Related]
2. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling. Yang Y; Chen M; Dimmitt R; Harmon CM Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793 [TBL] [Abstract][Full Text] [Related]
3. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation. Fleck BA; Ling N; Chen C Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565 [TBL] [Abstract][Full Text] [Related]
5. Point mutations in the melanocortin-4 receptor cause variable obesity in mice. Meehan TP; Tabeta K; Du X; Woodward LS; Firozi K; Beutler B; Justice MJ Mamm Genome; 2006 Dec; 17(12):1162-71. PubMed ID: 17143585 [TBL] [Abstract][Full Text] [Related]
6. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants. Sharma S; Thibodeau S; Lytton J Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884 [TBL] [Abstract][Full Text] [Related]
7. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach. Falls BA; Zhang Y ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism. Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227 [TBL] [Abstract][Full Text] [Related]
9. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands. Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383 [TBL] [Abstract][Full Text] [Related]
10. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity. Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227 [TBL] [Abstract][Full Text] [Related]
11. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17. Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist. Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274 [TBL] [Abstract][Full Text] [Related]
13. Functions of transmembrane domain 3 of human melanocortin-4 receptor. Mo XL; Yang R; Tao YX J Mol Endocrinol; 2012 Dec; 49(3):221-35. PubMed ID: 23014838 [TBL] [Abstract][Full Text] [Related]
14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
15. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Haskell-Luevano C; Cone RD; Monck EK; Wan YP Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754 [TBL] [Abstract][Full Text] [Related]
16. Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations. Wang ZQ; Tao YX Biochim Biophys Acta; 2011 Sep; 1812(9):1190-9. PubMed ID: 21729752 [TBL] [Abstract][Full Text] [Related]
17. Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH. Chapman KL; Kinsella GK; Cox A; Donnelly D; Findlay JB J Mol Biol; 2010 Aug; 401(3):433-50. PubMed ID: 20600126 [TBL] [Abstract][Full Text] [Related]
18. Mutations in melanocortin-4 receptor and human obesity. Tao YX Prog Mol Biol Transl Sci; 2009; 88():173-204. PubMed ID: 20374728 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. Ho G; MacKenzie RG J Biol Chem; 1999 Dec; 274(50):35816-22. PubMed ID: 10585465 [TBL] [Abstract][Full Text] [Related]
20. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors. Mo XL; Tao YX Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]